(Q40735588)

23 September 2017

1 reference

title

Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis (English)

1 reference

23 September 2017

0 references

1 reference

ChEBI release 2020-05-28

Reginster JY

1

1 reference

23 September 2017

publication date

1 December 1993

1 reference

23 September 2017

1 reference

23 September 2017

volume

23

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

223-232

1 reference

Flavonoids, a class of natural products of high pharmacological potency

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Modification of arachidonic metabolism by flavonoids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Structure-activity studies of flavonoids as inhibitors of hyaluronidase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Inhibition of tyrosine protein kinase activity by synthetic isoflavones and flavones

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Effect of catechins and citrus flavonoids on invasion in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Phytoestrogen interaction with estrogen receptors in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Antimicrobial activities of some flavonoid compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Effect of ipriflavone on the response of uterus and thyroid to estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Lack of any estrogenic effect of ipriflavone in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Flavonoids: biochemical effects and therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

The effect of ipriflavone (TC-80) on bone resorption in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Cytological and ultrastructural investigation on osteoblastic and preosteoclastic cells grown in vitro in the presence of ipriflavone: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Ipriflavone inhibits murine osteoclast formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Pharmacological control of osteoclastic motility

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Histochemical and fine structural study of bone of ipriflavone-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Stimulatory effect of ipriflavone on formation of bone-like tissue in rat bone marrow stromal cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Effect of ipriflavone on bone changes induced by calcium restricted, vitamin D deficient diet in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Suppressive effect of ipriflavone on bone depletion in the experimental diabetic rat: dose response of ipriflavone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Calcitonin secreting property of ipriflavone in the presence of estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Short-term treatment of Paget's disease of bone with ipriflavone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Effects of ipriflavone on bone remodeling in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

Effect of ipriflavone on bone mass in elderly osteoporotic women

1 reference

https://api.crossref.org/works/10.1016%2FS0169-6009%2808%2980099-2

7 January 2021

10.1016/S0169-6009(08)80099-2

Identifiers

DOI

1 reference

23 September 2017

1 reference